Procter & Gamble Health share news, announcements and annual reports
NSE: PGHLBSE: 500126Pharmaceuticals & BiotechnologySmall Cap
Procter & Gamble Health Limited · Formerly Merck · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1982 on BSE, Apr 1996 on NSE
Last close ₹5,670.50up ₹157.00 (2.85%)BSE ₹5,684.40
Share price at the NSE close on 30 Oct 2026. Previous close ₹5,513.50.
30 Oct: open ₹5,501.50, high ₹5,731.00, low ₹5,442.50
52-week range of traded prices to 30 Oct 2026
₹4,707.00Low, 6 Apr 2026₹6,975.00High, 15 Jul 2026
- Next results date: the board meets on 2 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹9,413 Cr585th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 26.37
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 17.94
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 3.62%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 67.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 84.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 13,61957.6% delivered
Procter & Gamble Health share news and announcements
562 announcements, routine notices left out, newest first. Page 10 of 12.
Jul 2013
Jun 2013
27 Jun · Board meeting
To Consider and approve the Un-audited Financial Results for the quarter ended June 30, 2013.
Apr 2013
26 Apr · Results
8 Apr · Board meeting
To consider and approve the Un-audited Financial Results for the quarter ended March 31, 2013.
Mar 2013
18 Mar · Disclosure of Voting Pattern - Clause 35A
Jan 2013
30 Jan · Meeting
Register of Members and the Share Transfer Books of the Company will remain closed from March 09, 2013 to March 15, 2013 (both days inclusive) for the purpose of payment of dividend for the year ended December 31, 2012 as may be declared at the forthcoming Annual General Meeting of the Company to be held on March 15, 2013.30 Jan · Dividend
Board of Directors of the Company at its meeting held on January 30, 2013 has recommended dividend at the rate of Rs.2.50/- (Rupees two and fifty paisa) per equity share of Rs.10/- each.
Oct 2012
22 Oct · Board meeting
To consider and approve the Unaudited Financial Results for the quarter ended September 30, 2012.8 Oct · Management
Upon attaining superannuation, Mr. R L Shenoy has resigned from the office of director and whole time director of the Company with effect from September 30, 2012. The Board of Directors of the Company at its ensuing meeting on October 22, 2012 will consider the appointment of an additional director and executive director in place of Mr. Shenoy.
Jul 2012
28 Jul · Management
Company has appointed Dr. Claus-Dieter Boedecker as an additional director and Managing Director of the Company w.e.f August 01, 2012 in place of Dr. Marek Dziki, present Managing Director of the Company, whose term is expiring on July 31, 2012. As such Dr. Marek Dizki will cease to be a director and Managing Director of the Company with effect from July 31, 2012.23 Jul · Results
3 Jul · Board meeting
To consider and approve the Un-audited Financial Results for the second quarter and half year ended June 30, 2012.
May 2012
22 May · Management
Mr H. U. Shenoy, Company Secretary of the Company has resigned w.e.f. May 11, 2012.
Apr 2012
20 Apr · Results
12 Apr · Disclosure of Voting Pattern - Clause 35A
10 Apr · Board meeting
To consider and approve the Un-audited Financial Results for the quarter ended March 31, 2012.
Mar 2012
7 Mar · Meeting
Annual General Meeting of the Company will be held on April 09, 2012. The Register of Members and the Share Transfer Books of the Company will be closed from March 29, 2012 to April 09, 2012 (both days inclusive).
Feb 2012
9 Feb · Board meeting
To consider and approve the Audited Financial Results for the year ended December 31, 2011.2 Feb · Board Meeting Postponed
Merck Limited had informed the Exchange regarding a meeting of Board of Directirs to be held on February 06, 2012 to take on record the Audited Financial Results for the year ended December 31, 2011. The Company has now informed the Exchange that the meeting to be held on February 06, 2012 has been postponed for want of quorum and the Company will intimate revised date of the meeting shortly.
Jan 2012
20 Jan · Board meeting
To take on record the Audited Financial Results for the year ended December 31, 2011.
Nov 2011
Oct 2011
5 Oct · Board meeting
To take on record the Unaudited Financial Results for the thrid quarter ended September 30, 2011.
Jul 2011
26 Jul · Results
13 Jul · Board meeting
To take on record the Un-audited Financial Results for the second quarter and half year ended June 30, 2011.
May 2011
Apr 2011
25 Apr · Management
Mr. K. Shivkumar, Director has resigned as a Director from the Board of Director of Merck Limited w.e.f. May 24, 2011.25 Apr · Results
8 Apr · Board meeting
To take on record the Un-audited Financial Results for the first quarter ended March 31, 2011.1 Apr · Meeting
Members at the Annual General Meeting (AGM) of the Company held on March 29, 2011, inter alia, have accorded to the following: 1) Approval of Audited Annual Accounts for the year ended December 31, 2010 and the Report of the Auditors and Directors thereon. - Approved; 2) Re-appointment of Mr. H.C.H Bhabha and Mr. K Shivkumar as Directors of the Company liable to retire by rotation - Re-appointed; 3) Re-appointment of M/s B.S.R. & Co., as Statutory Auditors of the Company. - Re-appointed; 4) Appointment of Mr. Pramod Pimplikar as a Director of the Company. - Appointed; 5) Appointment of Mr. Pramod Pimplikar as a Whole-time Director of the Company.- Appointed.
Feb 2011
10 Feb · Meeting
Annual General Meeting of the Company will be held on March 29, 2011. The Register of Members and the Share Transfer Books of the Company will be closed from March 23, 2011 to March 29, 2011 (both days inclusive) for the purpose of Annual General Meeting.
Jan 2011
21 Jan · Board meeting
To take on record the Audited Financial Results for the quarter and year ended December 31, 2010.
Nov 2010
18 Nov · Management
At the Meeting of the Board of Directors held on October 20, 2010 Mr Timothy Kneen has been appointed as a Non - Executive director in place of Mr. Ralph Antonius Zaat who has resigned with effect from October 20, 2010.
Oct 2010
20 Oct · Dividend
Board of Directors of the Company at its meeting held on October 20, 2010 has declared interim dividend of Rs.95/- per equity shares (950%).13 Oct · Corporate action
Company has fixed October 25, 2010 as the Record Date for the purpose of interim dividend.7 Oct · Board meeting
To take on record the Unaudited Financial Results for the third quarter ended September 30, 2010.
Jul 2010
13 Jul · Board meeting
To take on record the Unaudited Financial Results for the Second quarter and half year ended June 30, 2010.
Jun 2010
May 2010
19 May · Closure of Buy Back
Company has till May 19, 2010 bought back 261,842 Equity Shares and utilized an amount of Rs. 1037.31 lakhs i.e. 23% of the maximum buy back size. As per the terms of Public Announcement dated May 28, 2009, the Buyback will close with effect from May 19, 2010.